Account (2S,3S,4R,5R,6R)-6-(((2R,3R,4R,5R,6R)-6-(((2R,3S,4S,5R,6R)-2-Carboxy-4-hydroxy-6-(((2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfoamino)-2-((sulfooxy)methyl)tetrahydro-2H-pyran-3-yl)oxy)-5-(sulfooxy)tetrahydro-2H-pyran-3-yl)oxy)-5-(sulfoamino)-4-(sulfooxy)-2-((sulfooxy)methyl)tetrahydro-2H-pyran-3-yl)oxy)-3-(((2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfoamino)-6-((sulfooxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-4,5-dihydroxytetrahydro-2H-pyran-2-carboxylic acid, decasodium salt
- Catalog No.:
- ACIOCA470
- CAS No.:
- 114870-03-0
- Molecular Formula:
- C31H43N3Na10O49S8
- Molecular Weight:
- 1728.09
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%
10mg98%
25mg98%
50mg98%
100mg98%
250mg98%
1g98%
Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.
0 Reviews: View Reviews
Product Information
| Product Name | (2S,3S,4R,5R,6R)-6-(((2R,3R,4R,5R,6R)-6-(((2R,3S,4S,5R,6R)-2-Carboxy-4-hydroxy-6-(((2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfoamino)-2-((sulfooxy)methyl)tetrahydro-2H-pyran-3-yl)oxy)-5-(sulfooxy)tetrahydro-2H-pyran-3-yl)oxy)-5-(sulfoamino)-4-(sulfooxy)-2-((sulfooxy)methyl)tetrahydro-2H-pyran-3-yl)oxy)-3-(((2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfoamino)-6-((sulfooxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-4,5-dihydroxytetrahydro-2H-pyran-2-carboxylic acid, decasodium salt |
|---|---|
| IUPAC Name | sodium (2S,3S,4R,5R,6R)-6-(((2R,3R,4R,5R,6R)-6-(((2R,3S,4S,5R,6R)-2-carboxylato-4-hydroxy-6-(((2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfonatoamino)-2-((sulfonatooxy)methyl)tetrahydro-2H-pyran-3-yl)oxy)-5-(sulfonatooxy)tetrahydro-2H-pyran-3-yl)oxy)-5-(sulfonatoamino)-4-(sulfonatooxy)-2-((sulfonatooxy)methyl)tetrahydro-2H-pyran-3-yl)oxy)-3-(((2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfonatoamino)-6-((sulfonatooxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-4,5-dihydroxytetrahydro-2H-pyran-2-carboxylate |
| MDL No. | 0 |
| Molecular Formula | C31H43N3Na10O49S8 |
| Molecular Weight | 1728.09 |
| SMILES | [O-]S(N[C@H]([C@@H](OS([O-])(=O)=O)[C@@H]1O[C@@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O[C@H]([C@H](NS([O-])(=O)=O)[C@@H](O)[C@@H]3O)O[C@@H]3COS([O-])(=O)=O)C([O-])=O)[C@@H](O[C@@H]4[C@H](C([O-])=O)O[C@H]([C@@H]([C@H]4O)OS([O-])(=O)=O)O[C@@H]5[C@@H](COS([O-])(=O)=O)O[C@H](OC)[C@H](NS([O-])(=O)=O)[C@H]5O)O[C@@H]1COS([O-])(=O)=O)(=O)=O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+] |
| InChI Key | XEKSTYNIJLDDAZ-JASSWCPGSA-D |
| Synonym | FONDAPARINUX SODIUM [JAN] | GSK-576428 | IC-851589 | X0Q6N9USOZ | fondaparinux sodique | Xantidar | decasodium 6-[6-[2-carboxylato-4-hydroxy-6-[4-hydroxy-6-methoxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-5-sulfonatooxy-tetrahydro |
| CAS No. | 114870-03-0 |
| PubChem CID | 636380 |
Safety Data
- Pictogram
- Signal Word
- Warning
- Hazard Statement(s)
- H302-H319-H373
- Precautionary Statement(s)
- P260-P264-P270-P280-P301+P312+P330-P305+P351+P338-P314-P337+P313-P501
Synthetic Route by SureRoute
4-hydroxy-6-((4-hydroxy-6-methoxy-5-(sulfoamino)-2-((sulfooxy)methyl)tetrahydro-2H-pyran-3-yl)oxy)-3-methoxy-5-(sulfooxy)tetrahydro-2H-pyran-2-carboxylic acid
((2S,3R,4R,5R,6R)-5-Hydroxy-6-(hydroxymethyl)-2-methoxy-4-(sulfooxy)tetrahydro-2H-pyran-3-yl)sulfamic acid
Sodium (2S,3R,4R,5R,6R)-2,5-dihydroxy-6-(hydroxymethyl)-3-(sulfonatoamino)tetrahydro-2H-pyran-4-yl sulfate